Skip to main content
. 2016 Mar 11;4(5):763–773. doi: 10.3892/mco.2016.819

Table V.

Assessments of recurrence, metastasis and survival by either BR or CR analyses.

Recurrence Metastasis Survival



Variables BR or CR Variable(s) OR (95% CI) n Variable(s) OR (95% CI) n Variable(s) OR (95% CI) n
Clinicopathological (n=10)
  Age, intention of surgery, BR Localization 3.523
  localization, margin (1.204–10.314) 2 0 Multifocality 8.402 1
  status, grade (TNM), Margin status 5.486 (0.903–78.144)
  multifocality, gender, size, (0.924–32.569)
  tumor status (TNM), CR Localization 5.373 1.161
  type of surgery (1.742–16.571) 2 Size (0.982–1.374) 1 0
Margin status 5.132
(1.109–23.747)
Morphological (n=8)
  Growth pattern, BR Growth 6.043 Mitoses/50 HPFs 1.023
  histomorphological pattern (1.255–29.098) 1 (0.996–1.050) 2 0
  pattern, mitoses/50 HPFs, Growth pattern 4.726
  mucosal infiltration, (1.223–18.253)
  mucosal ulceration, CR Growth 13.715 Growth pattern 6.632
  nuclear pleomorphism, pattern (2.556–73.605) 1 (0.974–45.158) 1 0
  skeinoid fibers, tumor
  cell necrosis
Immunohistochemical (n=13)
  Bcl-2, CD117 (C-kit), BR CD34 0.991 Ki-67/mm2 1.002
  CD34, CD44, desmin, (0.983–0.999) 1 0 (1.000–1.004) 1
  DOG-1, Ki-67/mm2, CD34 0.992
  PDGFRα, PHH3, P16, (0.984–1.000)
  P53, SMA, S-100 CR 0 0 Ki-67/mm2 1.003
(1.001–1.004) 1
Total (n=31) BR/CR 4/3 2/2 3/1
Further risk classification of GIST cases based on predicted probabilities of margin status, localization, multifocality and growth pattern (see Fig.1 for Kaplan-Meier analyses).

All analysed variables are listed and the bold print indicates statistical significance. In the column of recurrence, metastasis and survival, the variables identified via multivariate statistical analysis are listed and the bold print indicates OR ≥5.0. BR, binary logistic regression; CR, Cox regression; OR, odds ratio; CI, confidence interval; HPFs, high-power fields; Bcl-2, B-cell lymphoma 2; DOG-1, discovered on GIST 1; PDGFRα, platelet-derived growth factor receptor α; PHH3, phosphohistone H3; SMA, smooth muscle actin.